He was given decadron 4 mg IV, and then given 40 mg IV decadron per neuro recs after MRI findings.
He was then transferred to the MICU for frequent neuro checks after the embolization.
Pertinent Results: Labs on admission:  [**2101-6-29**] 10:25PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2101-6-29**] 10:25PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.010 [**2101-6-29**] 10:25PM   PLT COUNT-218 [**2101-6-29**] 10:25PM   NEUTS-57.8 LYMPHS-32.3 MONOS-7.7 EOS-1.0 BASOS-1.2 [**2101-6-29**] 10:25PM   WBC-7.9 RBC-4.36* HGB-12.9* HCT-38.4* MCV-88 MCH-29.6 MCHC-33.6 RDW-15.3 [**2101-6-29**] 10:25PM   CALCIUM-10.5* PHOSPHATE-3.2 MAGNESIUM-2.0 [**2101-6-29**] 10:25PM   CK-MB-NotDone cTropnT-<0.01 [**2101-6-29**] 10:25PM   LIPASE-15 [**2101-6-29**] 10:25PM   ALT(SGPT)-45* AST(SGOT)-22 CK(CPK)-48 ALK PHOS-140* AMYLASE-31 TOT BILI-0.4 [**2101-6-29**] 10:25PM   GLUCOSE-118* UREA N-16 CREAT-1.5* SODIUM-135 POTASSIUM-3.9 CHLORIDE-95* TOTAL CO2-26 ANION GAP-18 [**2101-6-29**] 10:37PM   LACTATE-2.3* [**2101-6-29**] 10:37PM   LACTATE-2.3* [**2101-6-30**] 12:30PM   PT-14.2* INR(PT)-1.3* [**2101-6-30**] 05:58PM   PLT COUNT-212 .
Labs on Discharge:  [**2101-7-9**] 03:18PM BLOOD WBC-13.5* RBC-3.58* Hgb-10.3* Hct-30.6* MCV-86 MCH-28.9 MCHC-33.8 RDW-15.9* Plt Ct-243 [**2101-7-9**] 03:18PM BLOOD Plt Ct-243 [**2101-7-9**] 06:25AM BLOOD Glucose-135* UreaN-9 Creat-1.1 Na-137 K-4.6 Cl-98 HCO3-28 AnGap-16 [**2101-7-9**] 06:25AM BLOOD Calcium-9.1 Phos-3.1 Mg-2.3 [**2101-7-2**] 01:30AM BLOOD Type-ART pO2-131* pCO2-46* pH-7.38 calTCO2-28 Base XS-1  Brief Hospital Course: Spinal Metastasis:  The patient was admitted to the floor s/p tumor embolization, decompression, and fusion procedure.
He was admitted for pain contorl and medical monitoring.
He was taken off of bedrest and allowed to ambulate with assist.
His pain was contorlled initially with a dilaudid PCA with morphine prn for breakthrough pain.
He was transitioned over to oral pain management including MS Contin 30mg TID and oral dilaudid for breakthrough pain.
He tolerated pain well.
He moved his bowels and tolerated po intake.
He was discharged to follow up both with Ooncology and with Radiation Oncology.
Medications on Admission: Dilaudid PCA - basal rate 1mg/hr, .12mg/application Cefazolin x 3 doses s/p procedure Dexamethasone 10mg IV q 6h Insulin sliding scale   Discharge Medications: 1.
Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).
Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation Q6H (every 6 hours) as needed.
Hydromorphone 2 mg Tablet Sig: 2-4 Tablets PO Q3H (every 3 hours) as needed.
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
MS Contin 30 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO three times a day.
Dulcolax Stool Softener 100 mg Capsule Sig: One (1) Capsule PO twice a day.
Please take all medications as directed 2.
